Skip to main content
logo
DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam flag Vietnam · Delayed Price · Currency is VND
83,800
-1,000 (-1.18%)
At close: Nov 3, 2026

DHG Pharmaceutical JSC Balance Sheet

Millions VND. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
106,293129,89662,85894,13434,01843,374
Short-Term Investments
1,063,9612,024,0002,745,0001,960,0002,265,0001,975,000
Cash & Short-Term Investments
1,170,2542,153,8962,807,8582,054,1342,299,0182,018,374
Cash Growth
-54.39%-23.29%36.69%-10.65%13.90%-1.40%
Accounts Receivable
486,986584,930523,860528,859279,862315,113
Other Receivables
21,34279,72686,83896,07581,41777,757
Receivables
508,328664,792610,955625,192361,537393,141
Inventory
1,361,7911,024,6191,115,4291,534,6361,250,8341,072,606
Prepaid Expenses
28,5929,9968,6538,00710,2015,827
Other Current Assets
73,91435,46661,109420,224297,183237,346
Total Current Assets
3,142,8793,888,7684,604,0044,642,1934,218,7723,727,293
Property, Plant & Equipment
993,1371,012,5671,066,3751,187,884678,171631,658
Long-Term Investments
4,0884,6304,4384,1753,8604,578
Other Intangible Assets
172,327174,420178,106181,861201,812205,780
Long-Term Deferred Tax Assets
26,84125,92918,34016,87215,84517,535
Long-Term Deferred Charges
35,275-----
Other Long-Term Assets
35,12567,56787,98277,48949,72630,822
Total Assets
4,409,6715,173,8825,959,2436,110,4745,168,1874,617,666

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
313,342391,631167,297217,976364,379201,220
Accrued Expenses
368,287432,467339,445313,579227,615257,956
Short-Term Debt
--649,914572,165114,723207,391
Current Income Taxes Payable
9,5195,27222,41717,36512,6784,208
Current Unearned Revenue
47,46142,84248,50743,70234,04349,609
Other Current Liabilities
79,84893,737562,71324,45458,09837,332
Total Current Liabilities
818,456965,9501,790,2931,189,242811,537757,716
Other Long-Term Liabilities
74,14170,66774,19568,29865,11366,807
Total Liabilities
892,5961,036,6161,864,4881,257,540876,650824,523

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,307,4611,307,4611,307,4611,307,4611,307,4611,307,461
Additional Paid-In Capital
6,7796,7796,7796,7796,7796,779
Retained Earnings
2,202,8352,823,0262,780,5153,538,6952,977,2972,475,770
Total Common Equity
3,517,0754,137,2654,094,7554,852,9354,291,5373,790,010
Minority Interest
-----3,134
Shareholders' Equity
3,517,0754,137,2654,094,7554,852,9354,291,5373,793,144
Total Liabilities & Equity
4,409,6715,173,8825,959,2436,110,4745,168,1874,617,666

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
--649,914572,165114,723207,391
Net Cash (Debt)
1,170,2542,153,8962,157,9441,481,9692,184,2941,810,982
Net Cash Growth
-30.62%-0.19%45.61%-32.15%20.61%-1.30%
Net Cash Per Share
8950.5816473.8816504.8411334.7216706.3913851.14
Filing Date Shares Outstanding
130.75130.75130.75130.75130.75130.75
Total Common Shares Outstanding
130.75130.75130.75130.75130.75130.75
Working Capital
2,324,4232,922,8192,813,7113,452,9513,407,2362,969,577
Book Value Per Share
26900.0431643.5131318.3837117.2532823.4528987.56
Tangible Book Value
3,344,7483,962,8453,916,6494,671,0744,089,7253,584,230
Tangible Book Value Per Share
25582.0130309.4829956.1535726.3131279.9127413.67
Buildings
778,420776,236776,502575,489578,613528,464
Machinery
1,481,5511,423,7341,374,8261,029,566903,189866,975
Construction In Progress
50,47044,15848,614553,59492,59669,508